erythromycin has been researched along with cisapride in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 29 (42.65) | 18.2507 |
| 2000's | 31 (45.59) | 29.6817 |
| 2010's | 7 (10.29) | 24.3611 |
| 2020's | 1 (1.47) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Drenth, JP; Engels, LG | 1 |
| Baker, RA; Harvey, JR; Liu, YF; Saccone, GT; Thune, A; Toouli, J | 1 |
| Robinson, M | 1 |
| Patterson, DJ | 1 |
| Vantrappen, G | 1 |
| Ramirez, B; Richter, JE | 1 |
| Byrne, PJ; Freyne, P; Hamilton, D; Hennessy, TP; Hill, AD; O'Hare, N; Walsh, TN | 1 |
| Gallar, P; Guijo, G; Oliet, A; Ortega, O; Vigil, A | 1 |
| Arranz-Caso, JA; Botella, M; Cuadrado, LM; García de Tena, J | 1 |
| Inatomi, N; Itoh, Z; Marui, S; Omura, S; Sato, F | 2 |
| Gibson, J; Jenkins, IR | 1 |
| Bramlett, G; Langer, JC | 1 |
| Brandt, LJ; Greenwald, DA; Resnick, J | 1 |
| Andriulli, A; Annese, V; Bassotti, G; Frusciante, V; Germani, U; Lombardi, G | 1 |
| Czambor-Ksiazek, E; Duda, G; Grzeszczak, W; Pokrzywnicki, W | 1 |
| Dits, H; Frans, E; Malbrain, ML; Tack, J; Wilmer, A | 1 |
| Endres, SP; Folwaczny, C; König, A; Läritz, M; Meurer, M; Schindlbeck, N | 1 |
| Doi, I; Kawamura, O; Kusano, M; Mori, M; Motegi, K; Nakamura, K; Sekiguchi, T; Yanagisawa, M | 1 |
| Itoh, Z; Mizumoto, A; Mochiki, E; Omura, S; Suzuki, H; Tanaka, T | 1 |
| Toyota, K | 1 |
| Pelosini, I; Scarpignato, C | 1 |
| Hall, JA; Washabau, RJ | 1 |
| Torii, A | 1 |
| Francis, GS | 1 |
| Drici, MD; Ebert, SN; Liu, XK; Rodriguez, I; Wang, WX; Whitfield, BH; Woosley, RL | 1 |
| Bailey, TC; Frisse, ME; McMullin, ST; Reichley, RM; Steib, SA; Watson, LA | 1 |
| Boeckxstaens, GE; De Man, JG; De Winter, BY; Herman, AG; Moreels, TG; Peeters, TL; Pelckmans, PA; Schuurkes, JA | 1 |
| Brown, RO; Dickerson, RN; Gervasio, JM; Headley, S; Kudsk, KA; Kuhl, DA; Lima, JJ; Livingston, TN; MacLaren, R; Swift, K | 1 |
| Samsom, M; Smout, AJ; Van Herwaarden, MA; Van Nispen, CH; Verlinden, M | 1 |
| Besecke, LM; Cowles, VE; Faghih, R; Mohning, KM; Nellans, HN; Segreti, JA; Seifert, TR; Verlinden, MH; Wegner, CD | 1 |
| Marik, P; Zaloga, GP | 1 |
| Douya, R; Mushiroda, T; Nagata, O; Takahara, E | 1 |
| Gooszen, HG; Samsom, M | 1 |
| Cheng, TH; Regalado, M; Silang, R; Wesson, DE | 1 |
| Alimchandani, A; Pai-dhungat, JV | 1 |
| Cox, BF; Gintant, GA; Limberis, JT; McDermott, JS; Wegner, CD | 1 |
| Schuster-Bruce, M | 1 |
| Alonso Calderón, JL; García Aroca, J; García Redondo, C; Rollán Villamarín, V | 1 |
| Guerin, JM; Leibinger, F | 1 |
| Nieto, JE; Snyder, JR; Spier, SJ; Timmerman, BL; Van Hoogmoed, LM; Vatistas, NJ | 1 |
| Al-Wabel, NA; Hamlin, RL; Keene, BW; Nakayama, T; Strauch, SM | 1 |
| Dkhar, SA; Shashindran, CH; Shewade, DG; Suchitra, AD | 1 |
| Doherty, WL; Winter, B | 1 |
| Caenepeel, P; Cuomo, R; Janssens, J; Piessevaux, H; Tack, J | 1 |
| Bellomo, R; Davies, AR | 1 |
| Bryant, CA; Close, JC; Jackson, SH; Mangoni, AA; Rodriguez, S; Sherwood, RA; Swift, CG | 1 |
| Hauser, B; Salvatore, S; Vandenplas, Y | 2 |
| Cripps, PJ; Dallap, BL; Edwards, GB; Proudman, CJ; Smith, MA | 1 |
| Holst, JJ; Kemmeries, G; Meier, JJ; Nauck, MA | 1 |
| Chang, IS; Chi, CL; Chien, SY; Gau, CS; Huang, YW; Lin Wu, FL; Lin, KM; Liu, MY; Wang, HP; Yu, HT | 1 |
| Chapman, MJ; Fraser, RJ; Nguyen, NQ | 1 |
| Keady, S | 1 |
| Itoh, M; Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H | 1 |
| Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H | 1 |
| Itoh, Z; Koto, M; Omura, S; Onoma, M; Ozaki, K; Takanashi, H; Yogo, K | 1 |
| Akima, M; Itoh, Z; Kamei, K; Koga, H; Omura, S; Onoma, M; Ozaki, K; Takanashi, H; Yogo, K | 1 |
| Farré, R; Harris, MS; Janssen, P; Jones, M; Masaoka, T; Simrén, M; Tack, J; Törnblom, H; Van Oudenhove, L | 1 |
| Bollegala, NP; Khanna, R; Leontiadis, GI; Moayyedi, P; Pittayanon, R; Yuan, Y | 1 |
| Chen, Y; Cheng, D; Liu, H; Pan, L; Stalin, A; Wang, J; Wei, X; Xu, J; Yang, J; Yu, J; Zhang, Q; Zhang, Y; Zhao, W; Zhong, D | 1 |
18 review(s) available for erythromycin and cisapride
| Article | Year |
|---|---|
Diabetic gastroparesis. A critical reappraisal of new treatment strategies.
Topics: Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisapride; Diabetes Complications; Domperidone; Double-Blind Method; Erythromycin; Gastric Emptying; Humans; Metoclopramide; Piperidines; Stomach Diseases | 1992 |
Prokinetic therapy for gastroesophageal reflux disease.
Topics: Bethanechol; Cisapride; Domperidone; Erythromycin; Gastroesophageal Reflux; Humans; Metoclopramide; Parasympathomimetics; Piperidines | 1995 |
Prokinetic agents in postgastrectomy patients.
Topics: Bethanechol; Bethanechol Compounds; Cisapride; Domperidone; Erythromycin; Gastric Emptying; Humans; Metoclopramide; Piperidines; Postgastrectomy Syndromes | 1994 |
Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
Topics: Adult; Benzamides; Bethanechol; Bethanechol Compounds; Child; Cisapride; Erythromycin; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Infant; Metoclopramide; Piperidines; Receptors, Cholecystokinin; Serotonin Antagonists | 1993 |
Delayed gastric emptying and postoperative ileus after nongastric abdominal surgery: part II.
Topics: Abdomen; Cisapride; Dopamine Antagonists; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Humans; Intestinal Obstruction; Intubation, Gastrointestinal; Metoclopramide; Parasympathomimetics; Piperidines; Postoperative Complications; Protein Synthesis Inhibitors | 1997 |
[Disorders of gastric emptying in diabetes. II. Treatment].
Topics: Cisapride; Diabetes Complications; Domperidone; Dopamine Agents; Erythromycin; Gastric Emptying; Humans; Metoclopramide; Piperidines; Stomach Diseases | 1997 |
Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
Topics: Animals; Cisapride; Colonic Diseases, Functional; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Hormone Antagonists; Humans; Octreotide; Parasympatholytics; Proglumide; Receptors, Adrenergic, beta; Receptors, Cholecystokinin; Receptors, Muscarinic; Receptors, Neurokinin-2; Receptors, Serotonin; Serotonin Antagonists | 1999 |
Diagnosis and treatment of gastric motility disorders.
Topics: Animals; Cat Diseases; Cats; Cisapride; Dog Diseases; Dogs; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Metoclopramide; Nizatidine; Ranitidine; Stomach Diseases | 1999 |
Cardiac complications in the intensive care unit.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiovascular Diseases; Cisapride; Electrocardiography; Erythromycin; Female; Haloperidol; Histamine H1 Antagonists; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Risk Assessment; Survival Rate; Thrombolytic Therapy; United States; Water-Electrolyte Imbalance | 1999 |
Promotility agents in the intensive care unit.
Topics: Cisapride; Enteral Nutrition; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Gastroparesis; Humans; Intensive Care Units; Metoclopramide | 2000 |
[Treatment of severely delayed gastric emptying].
Topics: Cisapride; Diagnosis, Differential; Digestive System Surgical Procedures; Domperidone; Dyspepsia; Electric Stimulation Therapy; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Humans; Metoclopramide | 2000 |
Establishment of enteral nutrition: prokinetic agents and small bowel feeding tubes.
Topics: Australia; Cisapride; Critical Care; Enteral Nutrition; Erythromycin; Humans; Intestine, Small; Metoclopramide | 2004 |
Current pharmacological treatment of gastroparesis.
Topics: Adult; Child; Cisapride; Domperidone; Erythromycin; Gastrointestinal Agents; Gastroparesis; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Metoclopramide | 2004 |
The diagnosis and management of gastro-oesophageal reflux in infants.
Topics: Antacids; Cisapride; Domperidone; Erythromycin; Gastric Mucosa; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Metoclopramide; Risk Factors | 2005 |
Gastrointestinal motility and prokinetics in the critically ill.
Topics: Cisapride; Critical Care; Enteral Nutrition; Erythromycin; Esophagitis, Peptic; Gastric Emptying; Gastrointestinal Motility; Humans; Metoclopramide; Risk Factors | 2007 |
Update on drugs for gastro-oesophageal reflux disease.
Topics: Adolescent; Antacids; Child; Child, Preschool; Cisapride; Contraindications; Domperidone; Erythromycin; Gastroesophageal Reflux; Gastrointestinal Agents; Histamine Antagonists; Humans; Infant; Infant Food; Infant, Newborn; Metoclopramide; Proton Pump Inhibitors | 2007 |
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
Topics: Cisapride; Diabetes Mellitus, Type 2; Domperidone; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Humans; Metoclopramide; Severity of Illness Index; Sulpiride; Treatment Outcome | 2013 |
Prokinetics for functional dyspepsia.
Topics: Benzamides; Benzyl Compounds; Cisapride; Domperidone; Dyspepsia; Erythromycin; Gastrointestinal Agents; Humans; Indoles; Morpholines; Numbers Needed To Treat; Quality of Life; Randomized Controlled Trials as Topic; Thiazoles | 2018 |
6 trial(s) available for erythromycin and cisapride
| Article | Year |
|---|---|
Diabetic gastroparesis. A critical reappraisal of new treatment strategies.
Topics: Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisapride; Diabetes Complications; Domperidone; Double-Blind Method; Erythromycin; Gastric Emptying; Humans; Metoclopramide; Piperidines; Stomach Diseases | 1992 |
Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.
Topics: Acetaminophen; Administration, Oral; Adult; Aged; Antiemetics; Cisapride; Critical Illness; Cross-Over Studies; Enteral Nutrition; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Humans; Intestinal Absorption; Male; Metoclopramide; Middle Aged; Placebos; Respiration, Artificial; Time Factors | 2000 |
The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients.
Topics: Adult; Cisapride; Cross-Over Studies; Double-Blind Method; Erythromycin; Esophagus; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Motilin | 2000 |
Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying.
Topics: Cisapride; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Humans; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Nutrition Disorders; Renal Dialysis; Retrospective Studies; Serum Albumin | 2001 |
A study of gastric emptying in chronic renal failure.
Topics: Adolescent; Adult; Aged; Cisapride; Cross-Over Studies; Double-Blind Method; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 1997 |
Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia.
Topics: Adult; Analysis of Variance; Case-Control Studies; Cisapride; Cross-Over Studies; Double-Blind Method; Drinking; Dyspepsia; Energy Intake; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Humans; Male; Satiation; Sensitivity and Specificity; Serotonin Receptor Agonists; Sumatriptan | 2003 |
45 other study(ies) available for erythromycin and cisapride
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Sphincter of Oddi regulates flow by acting as a variable resistor to flow.
Topics: Animals; Bile; Cisapride; Erythromycin; Female; Male; Motilin; Opossums; Piperidines; Pressure; Sphincter of Oddi | 1992 |
Hastening gut transit.
Topics: Cisapride; Erythromycin; Gastrointestinal Transit; Humans; Motilin; Piperidines; Serotonin Antagonists; Time Factors | 1990 |
Acute colonic pseudo-obstruction.
Topics: Acute Disease; Cisapride; Colonic Pseudo-Obstruction; Erythromycin; Guanethidine; Humans; Neostigmine; Piperidines; Serotonin Antagonists | 1993 |
Erythromycin improves emptying of the denervated stomach after oesophagectomy.
Topics: Aged; Cisapride; Erythromycin; Esophageal Neoplasms; Esophagectomy; Female; Gastric Emptying; Humans; Male; Middle Aged; Piperidines; Pylorus; Serotonin Antagonists; Stomach Diseases; Vagotomy | 1993 |
Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin.
Topics: Cisapride; Diabetes Mellitus, Type 1; Erythromycin; Female; Gastric Emptying; Hospitalization; Humans; Male; Metoclopramide; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperidines; Serotonin Antagonists; Stomach Diseases; Vomiting | 1993 |
Prolonged colonic pseudo-obstruction (Ogilvie syndrome) in an older woman resolved with conservative treatment.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cisapride; Colonic Pseudo-Obstruction; Decompression; Erythromycin; Female; Humans; Parasympathomimetics; Parenteral Nutrition; Piperidines | 1996 |
Vagus-dependent and vagus-independent mechanisms of action of the erythromycin derivative EM574 and motilin in dogs.
Topics: Animals; Cisapride; Dogs; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Intestine, Small; Male; Motilin; Piperidines; Serotonin Receptor Agonists; Stomach; Vagus Nerve | 1996 |
Cisapride, erythromycin and arrhythmia.
Topics: Adult; Anti-Bacterial Agents; Cisapride; Drug Interactions; Erythromycin; Humans; Male; Piperidines; Tachycardia, Ventricular | 1996 |
Effect of prokinetic agents on ileal contractility in a rabbit model of gastroschisis.
Topics: Abdominal Muscles; Animals; Animals, Newborn; Bethanechol; Cisapride; Congenital Abnormalities; Erythromycin; Female; Gastrointestinal Agents; Gastrointestinal Motility; Ileum; In Vitro Techniques; Metoclopramide; Muscle Contraction; Octreotide; Piperidines; Rabbits | 1997 |
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Cisapride; Diabetes Mellitus, Type 1; Erythromycin; Female; Gastric Emptying; Gastroparesis; Humans; Male; Middle Aged; Piperidines; Serotonin Antagonists | 1997 |
Gastric emptying in the critically ill--the way forward.
Topics: Cisapride; Critical Illness; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Humans; Piperidines | 1997 |
[Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Topics: Aged; Cisapride; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Male; Middle Aged; Octreotide; Piperidines; Scleroderma, Systemic; Sympathomimetics; Treatment Outcome | 1997 |
[Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)].
Topics: Aged; Chronic Disease; Cisapride; Drug Therapy, Combination; Erythromycin; Female; Gastrointestinal Agents; Humans; Intestinal Pseudo-Obstruction | 1998 |
Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
Topics: Animals; Cisapride; Clonidine; Dogs; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Muscle Contraction; Postprandial Period; Stomach | 1998 |
Pyloric opening and closure evaluated by means of strain gauge force transducers.
Topics: Animals; Cisapride; Dogs; Duodenum; Erythromycin; Female; Gastrointestinal Agents; Gastrointestinal Motility; Male; Motilin; Muscle Contraction; Pyloric Antrum; Pylorus; Transducers | 1998 |
[Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)].
Topics: Chronic Disease; Cisapride; Drug Therapy, Combination; Erythromycin; Gastrointestinal Agents; Humans; Informed Consent; Intestinal Pseudo-Obstruction; Monitoring, Physiologic | 1999 |
Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart.
Topics: Animals; Cisapride; Dose-Response Relationship, Drug; Electrocardiography; Erythromycin; Female; Gastrointestinal Agents; Heart; In Vitro Techniques; Indoles; Perfusion; Rabbits | 1999 |
Impact of a Web-based clinical information system on cisapride drug interactions and patient safety.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Antifungal Agents; Azoles; Cisapride; Clarithromycin; Clinical Pharmacy Information Systems; Drug Information Services; Drug Interactions; Erythromycin; Gastrointestinal Agents; Humans; Internet; Retrospective Studies | 1999 |
Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats.
Topics: Animals; Cisapride; Dopamine Antagonists; Erythromycin; Gastrointestinal Agents; Granisetron; Intestinal Obstruction; Male; Metoclopramide; Postoperative Complications; Random Allocation; Rats; Rats, Wistar; Serotonin Antagonists | 1999 |
EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs.
Topics: Animals; Atropine; Cisapride; Dogs; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Male; Motilin; Muscarinic Antagonists; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin Receptor Agonists | 2000 |
Effect of novel motilide ABT-229 versus erythromycin and cisapride on gastric emptying in dogs.
Topics: Animals; Cisapride; Dogs; Dose-Response Relationship, Drug; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Motility; Muscle Contraction | 2000 |
The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate.
Topics: Administration, Oral; Animals; Antiemetics; Area Under Curve; Benzamides; Benzyl Compounds; Cimetidine; Cisapride; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dealkylation; Enzyme Stability; Erythromycin; Hot Temperature; Isoenzymes; Ketoconazole; Male; Microsomes, Liver; Mixed Function Oxygenases; Morpholines; Oxygen; Oxygenases; Rats; Rats, Sprague-Dawley | 2000 |
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
Topics: Action Potentials; Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cisapride; Dogs; Erythromycin; Female; Fluoroquinolones; Imidazoles; In Vitro Techniques; Indoles; Long QT Syndrome; Male; Models, Biological; Moxifloxacin; Perfusion; Piperazines; Purkinje Fibers; Quinolines; Sotalol; Swine; Torsades de Pointes | 2001 |
Gastric emptying in the critically ill.
Topics: Cisapride; Critical Illness; Dopamine Antagonists; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Humans; Metoclopramide | 2001 |
[Anorexia nervosa or somatic disease].
Topics: Adolescent; Anorexia Nervosa; Cisapride; Erythromycin; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Male; Manometry; Somatoform Disorders | 2001 |
Why not to use erythromycin in GI motility.
Topics: Cisapride; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Metoclopramide; Respiration, Artificial | 2002 |
Use of an extracorporeal circuit to evaluate effects of intraluminal distention and decompression on the equine jejunum.
Topics: Albumins; Animals; Cisapride; Erythromycin; Extracorporeal Circulation; Horses; Intestinal Mucosa; Jejunum; Metoclopramide; Muscle Contraction; Vascular Resistance | 2002 |
Electrocardiographic and hemodynamic effects of cisapride alone and combined with erythromycin in anesthetized dogs.
Topics: Anesthesia, Intravenous; Animals; Cisapride; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Electrocardiography; Erythromycin; Female; Hemodynamics; Injections, Intravenous; Male | 2002 |
Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice.
Topics: Animals; Benzamides; Cisapride; Domperidone; Drug Interactions; Erythromycin; Female; Gastric Emptying; Gastrointestinal Transit; Male; Metoclopramide; Mice; Morphine; Morpholines | 2003 |
Prokinetic agents in critical care.
Topics: Cisapride; Critical Care; Dose-Response Relationship, Drug; Enteral Nutrition; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Metoclopramide; Outcome and Process Assessment, Health Care; Research Design; Treatment Outcome | 2003 |
Acute hypotensive effects of oral cisapride and erythromycin in healthy subjects.
Topics: Administration, Oral; Blood Pressure; Cisapride; Erythromycin; Female; Gastrointestinal Agents; Heart Rate; Humans; Hypotension; Male; Middle Aged | 2004 |
Evaluation of the clinical efficacy of prokinetic drugs in the management of post-operative ileus: can retrospective data help us?
Topics: Animals; Cisapride; Digestive System Surgical Procedures; Erythromycin; Gastrointestinal Agents; Horse Diseases; Horses; Ileus; Lidocaine; Metoclopramide; Retrospective Studies; Risk Factors | 2005 |
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cisapride; Domperidone; Eating; Erythromycin; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Male; Metoclopramide; Peptide Fragments; Placebos; Protein Precursors; Reference Values | 2005 |
Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cisapride; Databases, Factual; Dose-Response Relationship, Drug; Drug Prescriptions; Drug Therapy, Combination; Erythromycin; Gastrointestinal Agents; Heart Diseases; Humans; Infant; Insurance Claim Review; Insurance, Pharmaceutical Services; Middle Aged; National Health Programs; Pneumonia; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Risk Assessment; Taiwan | 2007 |
Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin.
Topics: Action Potentials; Animals; Cell Line; Cisapride; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Gastrointestinal Agents; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Potassium Channel Blockers; Rabbits; Risk Assessment; Time Factors; Torsades de Pointes; Transfection | 2007 |
Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
Topics: Action Potentials; Anesthesia, General; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cisapride; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Halothane; Heart Rate; Infusions, Intravenous; Long QT Syndrome; Male; Models, Animal; Risk Assessment; Time Factors; Torsades de Pointes; Ventricular Function, Left; Ventricular Pressure | 2007 |
Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Animals; Cisapride; Consciousness; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Macaca mulatta; Male | 2008 |
Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Topics: Acetaminophen; Administration, Oral; Animals; Cisapride; Clonidine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Duodenum; Erythromycin; Gastric Emptying; Gastric Mucosa; Gastrointestinal Agents; Gastrointestinal Motility; Gastroparesis; Postprandial Period; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Stomach; Time Factors; Vagotomy | 2008 |
The Strength of hERG Inhibition by Erythromycin at Different Temperatures Might Be Due to Its Interacting Features with the Channels.
Topics: Cisapride; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Heart; Potassium Channel Blockers; Temperature | 2023 |